Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001081138 | SCV000557859 | likely benign | Hereditary hemorrhagic telangiectasia | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000834993 | SCV000976766 | likely benign | not provided | 2018-04-17 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
NIHR Bioresource Rare Diseases, |
RCV001262059 | SCV001439439 | likely benign | Telangiectasia, hereditary hemorrhagic, type 1 | 2018-01-01 | criteria provided, single submitter | research | BS1 +BP2+BP6 |
Genetic Services Laboratory, |
RCV001821326 | SCV002065662 | likely benign | not specified | 2019-04-04 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002402331 | SCV002712294 | likely benign | Cardiovascular phenotype | 2017-09-20 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |